Gregory C. Ireton, PhD
Scientist I
Greg Ireton is a native of the Northwest and obtained his BSc in Microbiology (Hons) from the University of Washington in 1994. After graduation, Greg worked as a research technician (1994-1999) in the Department of Microbiology, focusing on the biochemical and kinetic properties of human topoisomerase I with the anti-tumor drug camptothecin. Greg entered graduate studies in the Molecular and Cellular Biology Program at the University of Washington in 1999, studying protein x-ray crystallography and protein design in the laboratory of Barry Stoddard at the Fred Hutchinson Cancer Research Center. Greg collaborated with scientists at Washington State University working on enzymes for novel cancer therapies and completed his thesis,"Structural studies of yeast and bacterial cytosine deaminases: directed evolution and implications for anti-cancer gene therapy" in September of 2003.
Greg joined IDRI's Process Science Group as an Associate Scientist/Biochemist in 2003. Greg is currently working on projects related to the biochemical characterization and development of IDRI's next generation vaccine for leishmaniasis. Greg is also focused on leprosy antigen discovery, using bioinformatics to aid in the selection and design of new candidate antigens for the development of improved rapid diagnostic tests for leprosy.
- Steven G. Reed, PhD - Head of Research and Development, IDRI Founder
- Steve Davis, MA, JD - Interim Chief Executive Officer
- Curtis D. Malloy, JD, MPH - President, Director of Legal Affairs
- Jill Ashman, MSc - Senior Clinical Research Manager
- Susan Baldwin, PhD - Senior Scientist
- Anna Marie Beckmann, PhD - Head of Product Development
- Sylvie Bertholet, PhD - Senior Scientist
- Ajay Bhatia, PhD - Senior Scientist
- Darrick Carter, PhD - Director of Formulations
- Allen Casey - Group Leader, High Throughput Screening/Robotics
- James Chesko, PhD - Senior Scientist
- Therese Coad, CPA - Director of Finance
- Jessica Cohen, JD - Assistant General Counsel
- Rhea N. Coler, PhD - Director of Preclinical Biology
- Karen D. Cowgill, PhD, MSc - Clinical Research Manager
- Malcolm S. Duthie, PhD - Scientist II
- Yasuyuki Goto, PhD - Scientist I
- Alice Grasset, DVM, MBA - Project Manager
- Randall F Howard, PhD - Project Manager
- Gregory C. Ireton, PhD - Scientist I
- Edward A. Kesicki, PhD - Director, Small-Molecule Drug Discovery
- Karen Kinch - Vice President of Administration
- Joshua Oluoch Odingo, PhD - Director of Chemistry
- Tanya Parish, PhD - Senior Scientist / Principal Investigator
- Franco M. Piazza, MD, MPH - Medical Director
- Vanitha S. Raman, PhD - Scientist I
- David Roberts, PhD - Scientist I
- Angela Gollnick Schroeder, MBA - Project Manager
- Paul Sleath, PhD - Consultant, Manufacturing
- Thomas Vedvick, PhD - Director of Process Sciences
- Winston Wicomb, PhD, LATG - Senior Scientist / Animal Facility Manager